ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,430 | -23.7% | 11,455 | -6.1% | 0.00% | – |
| Q2 2023 | $81,828 | -23.6% | 12,195 | +0.6% | 0.00% | – |
| Q1 2023 | $107,073 | +21.7% | 12,126 | -1.6% | 0.00% | -100.0% |
| Q3 2022 | $88,000 | +877.8% | 12,317 | +966.4% | 0.00% | – |
| Q2 2022 | $9,000 | -57.1% | 1,155 | -24.4% | 0.00% | – |
| Q1 2022 | $21,000 | -4.5% | 1,528 | +98.4% | 0.00% | – |
| Q4 2021 | $22,000 | +10.0% | 770 | +30.5% | 0.00% | – |
| Q3 2021 | $20,000 | -16.7% | 590 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -59.3% | 590 | -59.6% | 0.00% | -100.0% |
| Q1 2021 | $59,000 | -15.7% | 1,460 | +22.7% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | +18.6% | 1,190 | -0.5% | 0.00% | 0.0% |
| Q3 2020 | $59,000 | – | 1,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |